Dietary supplementation with nacre reduces cortical bone loss in aged female mice.
Aging
Animal experimentation
Bone
Nacre
Osteoporosis
Journal
Experimental gerontology
ISSN: 1873-6815
Titre abrégé: Exp Gerontol
Pays: England
ID NLM: 0047061
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
04
05
2023
revised:
17
08
2023
accepted:
22
11
2023
pubmed:
26
11
2023
medline:
26
11
2023
entrez:
25
11
2023
Statut:
ppublish
Résumé
Aging is associated with detrimental bone loss leading to fragility fractures in both men and women. Notably, a majority of bone loss with aging is cortical, as well as a large number of fractures are non-vertebral and at the non-hip sites. Nacre is a product of mollusks composed of calcium carbonate embedded in organic components. As our previous study demonstrated the protective effect of nacre supplementation on trabecular bone loss in ovariectomized rats, we sought to evaluate the effect of dietary nacre on bone loss related to aging in female mice which do not suffer true menopause as observed in women. The current study compared the effect of a 90-day long nacre-supplemented diet to that of Standard or CaCO
Identifiants
pubmed: 38006949
pii: S0531-5565(23)00258-9
doi: 10.1016/j.exger.2023.112337
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112337Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest MR provides scientific consultation for Megabiopharma. TT reports receiving lecture fees from Amgen, Arrow, Biogen, BMS, Chugai, Galapagos, Grunenthal, Jansen, LCA, Lilly, MSD, Nordic, Novartis, Pfizer, Sanofi, Thuasne, Theramex, UCB and research grants or investigator's fees from Bone Therapeutics, UC. HM reports fees from Amgen, Arrow, Biogen, BMS, CellTrion, Chugai, Galapagos, Fresenius Kabi, Jansen, Lilly, MSD, Nodic, Novartis, Pfizer, Sanofi, and UCB. All other authors state that they have no conflicts of interest.